150 related articles for article (PubMed ID: 25496770)
1. Acinetobacter baumannii OxPhos inhibitors as selective anti-infective agents.
Rubin H; Selwood T; Yano T; Weaver DG; Loughran HM; Costanzo MJ; Scott RW; Wrobel JE; Freeman KB; Reitz AB
Bioorg Med Chem Lett; 2015 Jan; 25(2):378-83. PubMed ID: 25496770
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of novel isothiazolones with potent bactericidal activity against multi-drug resistant Acinetobacter baumannii clinical isolates.
Luna BL; Garcia JA; Huang M; Ewing PJ; Valentine SC; Chu YM; Ye QZ; Xu HH
Int J Antimicrob Agents; 2019 Apr; 53(4):474-482. PubMed ID: 30593847
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the Antimicrobial Activity of
Fleeman R; Van Horn KS; Barber MM; Burda WN; Flanigan DL; Manetsch R; Shaw LN
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28289036
[TBL] [Abstract][Full Text] [Related]
4. The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Huigens RW; Reyes S; Reed CS; Bunders C; Rogers SA; Steinhauer AT; Melander C
Bioorg Med Chem; 2010 Jan; 18(2):663-74. PubMed ID: 20044260
[TBL] [Abstract][Full Text] [Related]
5. Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model.
Lood R; Winer BY; Pelzek AJ; Diez-Martinez R; Thandar M; Euler CW; Schuch R; Fischetti VA
Antimicrob Agents Chemother; 2015 Apr; 59(4):1983-91. PubMed ID: 25605353
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel 1,2,5-oxadiazoles and evaluation of action against Acinetobacter baumannii.
Christoff RM; Murray GL; Kostoulias XP; Peleg AY; Abbott BM
Bioorg Med Chem; 2017 Dec; 25(24):6267-6272. PubMed ID: 29032931
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel inhibitors of multidrug-resistant Acinetobacter baumannii.
Soojhawon I; Pattabiraman N; Tsang A; Roth AL; Kang E; Noble SM
Bioorg Med Chem; 2017 Oct; 25(20):5477-5482. PubMed ID: 28830719
[TBL] [Abstract][Full Text] [Related]
8. Small Molecule Potentiation of Gram-Positive Selective Antibiotics against
Martin SE; Melander RJ; Brackett CM; Scott AJ; Chandler CE; Nguyen CM; Minrovic BM; Harrill SE; Ernst RK; Manoil C; Melander C
ACS Infect Dis; 2019 Jul; 5(7):1223-1230. PubMed ID: 31002491
[TBL] [Abstract][Full Text] [Related]
9. Identification and bioevaluation of SRI-12742 as an antimicrobial agent against multidrug-resistant Acinetobacter baumannii.
Shukla M; Soni I; Matsuyama K; Tran T; Tanga M; Gong L; Chopra S
Int J Antimicrob Agents; 2018 Jul; 52(1):22-27. PubMed ID: 29501820
[TBL] [Abstract][Full Text] [Related]
10. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Tiwari V; Tiwari D; Patel V; Tiwari M
Microb Pathog; 2017 Sep; 110():345-351. PubMed ID: 28705748
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
12. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial properties of brevinin-2-related peptide and its analogs: Efficacy against multidrug-resistant Acinetobacter baumannii.
Conlon JM; Ahmed E; Condamine E
Chem Biol Drug Des; 2009 Nov; 74(5):488-93. PubMed ID: 19793185
[TBL] [Abstract][Full Text] [Related]
14. A novel series of enoyl reductase inhibitors targeting the ESKAPE pathogens, Staphylococcus aureus and Acinetobacter baumannii.
Kwon J; Mistry T; Ren J; Johnson ME; Mehboob S
Bioorg Med Chem; 2018 Jan; 26(1):65-76. PubMed ID: 29162308
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.
Bowler SL; Spychala CN; McElheny CL; Mettus RT; Doi Y
Antimicrob Agents Chemother; 2016 Aug; 60(8):5101. PubMed ID: 27270280
[No Abstract] [Full Text] [Related]
16. Synthesis and antibiofilm evaluation of 3-hydroxy-2,3-dihydroquinazolin-4(1H)-one derivatives against opportunistic pathogen Acinetobacter baumannii.
Yang G; Cheng C; Xu GB; Tang L; Chua KL; Yang YY
Bioorg Med Chem; 2020 Aug; 28(16):115606. PubMed ID: 32690261
[TBL] [Abstract][Full Text] [Related]
17. Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase.
Songsungthong W; Yongkiettrakul S; Bohan LE; Nicholson ES; Prasopporn S; Chaiyen P; Leartsakulpanich U
Sci Rep; 2019 Oct; 9(1):15625. PubMed ID: 31666629
[TBL] [Abstract][Full Text] [Related]
18. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology and clinical features of Acinetobacter baumannii infections in humans].
Wisplinghoff H; Seifert H
Berl Munch Tierarztl Wochenschr; 2014; 127(11-12):447-57. PubMed ID: 25872254
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
